Strategies for manipulating the p53 pathway in the treatment of human cancer

Ted R. Hupp(Edinburgh Cancer Research), Kathryn L. Ball(Skidmore College)

Biochemical Journal

November 7, 2000

10.1042/bj3520001

Cited by 146

Related Papers

The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine

|PLoS ONE|2016|94

The Emergence of the Conserved AAA+ ATPases Pontin and Reptin on the Signaling Landscape <b>Meeting Information:</b> The First International Workshop on Pontin (RUVBL1) and Reptin (RUVBL2) took place at the European Institute for Chemistry and Biology in Pessac, France, 16 to 19 October 2012.

|Science Signaling|2013|56

A Central Role for CK1 in Catalyzing Phosphorylation of the p53 Transactivation Domain at Serine 20 after HHV-6B Viral Infection

|Journal of Biological Chemistry|2008|44

Spatial dynamics of IFITM1: a core component of the interferon-stimulated gene-resistance signature in glioma

|bioRxiv (Cold Spring Harbor Laboratory)|2025|0